ImmunoIVD AB
ABActiveOrg 5590180732Nacka StrandResearch and experimental development on natural sciences and engineering· NACE 7210Est. 2015 · 11 years old30 employees
Loading company…
Overview
ImmunoIVD AB is a Swedish AB based in Nacka Strand, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2015, the company has 30 employees and reported revenue of SEK 68.9m in its latest annual filing.
Revenue 2025
68.9M SEK
+18% vs 2024
EBITDA margin
26.4 %
+9% vs 2024
Net profit 2025
9.1M SEK
-14% vs 2024
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Financial development
In its most recent annual report (2025), ImmunoIVD AB reported revenue of SEK 68.9m, an increase of 18% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net profit of SEK 9.1m, and the EBITDA margin stood at 26.4%.
At the end of 2025, equity financed 50.5% of the balance sheet, and current assets covered short-term debt 2.1 times.
Financials
Get a credit rating – not just the numbers
Financial statements show the past. Risika gives you a score and a recommended credit limit, so you know what the numbers mean for your risk.
People & ownership
One in three Danish companies experiences fraud
Sound familiar? See how to strengthen your defences and catch suspicious changes in ownership and management in time.
Pabros AB
ImmunoIVD AB